Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Karen Hager, Gonzalo Pérez Marc, Philipe Gobeil, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2084-2096
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 285
Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
Zhirong Yang, Yi-Wen Jiang, Fu-Xiao Li, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 4, pp. e236-e246
Open Access | Times Cited: 89
Plant-based biopharmaceutical engineering
Lukas Eidenberger, Benjamin Kogelmann, Herta Steinkellner
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 6, pp. 426-439
Open Access | Times Cited: 69
Platforms, advances, and technical challenges in virus-like particles-based vaccines
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
Xiaodi Wu, Ke Xu, Ping Zhan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Globally approved vaccines for COVID-19: a systematic review
Bárbara Magalhães, Jéssica Medeiros Minasi, Rubens Cáurio Lobato, et al.
Brazilian Journal of Microbiology (2025)
Closed Access | Times Cited: 1
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Does the World Still Need New Covid-19 Vaccines?
Hanna Nohynek, Annelies Wilder‐Smith
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2140-2142
Open Access | Times Cited: 45
The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 38
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 30
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
The Lancet Regional Health - Europe (2023) Vol. 28, pp. 100613-100613
Open Access | Times Cited: 24
A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety
Md. Aminul Islam
Infectious Medicine (2023) Vol. 2, Iss. 4, pp. 247-261
Open Access | Times Cited: 24
Synthetic biology for plant genetic engineering and molecular farming
Yunqing Wang, Gözde S. Demirer
Trends in biotechnology (2023) Vol. 41, Iss. 9, pp. 1182-1198
Closed Access | Times Cited: 22
Progress and prospect: Biosynthesis of plant natural products based on plant chassis
Junjie Lin, Xue Yin, Youran Zeng, et al.
Biotechnology Advances (2023) Vol. 69, pp. 108266-108266
Closed Access | Times Cited: 21
Research progress on emulsion vaccine adjuvants
Zhuanqing Huang, Hui Gong, Qi Sun, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24662-e24662
Open Access | Times Cited: 11
Plant-Derived Human Vaccines: Recent Developments
Jennifer Stander, Sandiswa Mbewana, Ann E. Meyers
BioDrugs (2022) Vol. 36, Iss. 5, pp. 573-589
Open Access | Times Cited: 36
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
SubbaRao V. Tulimilli, Siva Dallavalasa, Chaithanya G. Basavaraju, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1751-1751
Open Access | Times Cited: 28
Plant glycoengineering for designing next-generation vaccines and therapeutic proteins
Richard Strasser
Biotechnology Advances (2023) Vol. 67, pp. 108197-108197
Open Access | Times Cited: 20
Delivery of biologics: Topical administration
Rachel J. Kulchar, Rahul Singh, Suwan Ding, et al.
Biomaterials (2023) Vol. 302, pp. 122312-122312
Open Access | Times Cited: 20
Nanocarrier vaccine therapeutics for global infectious and chronic diseases
Faizan Zarreen Simnani, Dibyangshee Singh, Paritosh Patel, et al.
Materials Today (2023) Vol. 66, pp. 371-408
Open Access | Times Cited: 18
A perspective on SARS-CoV-2 virus-like particles vaccines
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 17
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, et al.
Life (2023) Vol. 13, Iss. 3, pp. 617-617
Open Access | Times Cited: 15
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters
Emmanuel Margolin, Georgia Schäfer, Joel D. Allen, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 15
The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6
Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy
Abdellatif Bouazzaoui, Ahmed A. H. Abdellatif
Vaccine X (2024) Vol. 19, pp. 100500-100500
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top